Douglas Tremblay, MD

home / authors / douglas-tremblay-md

Articles

Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies

Kelsey Sokol, MD;Douglas Tremblay, MD;Sheena Bhalla, MD;Raajit Rampal, MD, PhD;John O. Mascarenhas, MD

May 15th 2018

In this second part of our two-part review, we discuss the use of mutation profiling in the diagnosis, prognosis, and treatment of patients with myeloproliferative neoplasms and other myeloid diseases.

Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia

Douglas Tremblay, MD;Kelsey Sokol, MD;Sheena Bhalla, MD;Raajit Rampal, MD, PhD;John O. Mascarenhas, MD

April 15th 2018

In this first part of our two-part review, we introduce mutation profiling as a relevant clinical tool for hematologists treating patients with myeloid malignancies.